The salaries of supply chain professionals increased faster than overall U.S. wage gains in 2017, according to data from the Institute for Supply Management cited by The Wall Street Journal.  By Mackenzie Bean - 5/21/18

Pfizer earned FDA approval for its drug Retacrit — a biosimilar version of the anemia therapy Epogen/Procrit — May 15.  By Mackenzie Bean - 5/18/18

Amgen will charge $6,900 per year for its migraine prevention drug — a price 30 percent lower than Wall Street expectations — as the company attempts to dodge the payer backlash that has affected recent drug launches, according to STAT.  By Alia Paavola - 5/18/18

The FDA on May 16 released a list of drug companies that may be using "gaming tactics" to delay generic competition from hitting the market.  By Mackenzie Bean - 5/17/18

Vermont Republican Gov. Phil Scott signed a bill May 16 to permit the importation of cheaper prescription drugs from Canada, reports Politico.  By Mackenzie Bean - 5/17/18

James Harrison, an 81-year-old Australian man, has donated his blood every few weeks for the past 60 years, helping save millions of newborns' lives, reports The New York Times.  By Mackenzie Bean - 5/15/18

Janssen Biotech and Pharmacyclics withdrew a proposed plan to introduce a new version of their blood cancer drug Imbruvica at triple the cost of the original, reports The Washington Post.  By Mackenzie Bean - 5/15/18

President Donald Trump presented his long-awaited "blueprint" to combat rising drug prices May 11, and despite previous remarks stating the pharmaceutical industry is "getting away with murder," Trump largely spares drugmakers from sweeping reform, according to The New York Times.  By Alia Paavola - 5/15/18

Amazon is making its move into healthcare by launching an exclusive line of 60 over-the-counter healthcare products and expanding its business-to-business marketplace to sell medical supplies to hospitals and clinics, and 62 percent of hospital leaders are supportive of the e-commerce giant's plan, according to a survey published by Reaction Data, a healthcare research and consulting firm.  By Alia Paavola - 5/15/18

The FDA approved a pediatric indication for Novartis' multiple sclerosis drug Gilenya, the drugmaker announced May 11.  By Mackenzie Bean - 5/14/18

Boston Scientific is involved in tens of thousands of lawsuits filed by women who experienced health complications related to the devicemaker's gynecological mesh implants, according to a "60 Minutes" report aired May 13.  By Mackenzie Bean - 5/14/18

Here are the five latest drugs or medical devices approved by the FDA since April 27.  By Mackenzie Bean - 5/11/18

As prescription drug prices continue to rise and the popularity of high-deductible health plans grow, patients across the U.S. are shouldering the higher price of their medications.  By Alia Paavola - 5/11/18

After combing through 149 proposals for its Unmanned Aircraft Systems Integration Pilot Program — which seeks to operationalize drones in safe and unique ways — the U.S. Department of Transportation, in partnership with the Federal Aviation Administration, selected 10 winners May 9.     By Alia Paavola - 5/10/18

Eli Lilly and Co. entered a definitive agreement to purchase the immuno-oncology company Armo BioSciences for about $1.6 billion, the drugmaker announced May 10.  By Mackenzie Bean - 5/10/18

Salix Pharmaceuticals aims to simplify the preparation process for colonoscopies with its new FDA-approved bowel cleanser, Plenvu, the company announced May 7.  By Mackenzie Bean - 5/9/18

Jazz Pharmaceuticals will pay $57 million as part of a tentative deal with the U.S. Department of Labor to settle an investigation into the drugmaker's donations to patient assistance charities, reports Bloomberg.  By Mackenzie Bean - 5/9/18

Takeda Pharmaceutical Co. acquired its much larger rival Shire for $62 billion in cash and stock — a deal that catapults the Japanese company into a new league of drug industry giants, according to Bloomberg.  By Alia Paavola - 5/9/18

The FDA posted a supply shortage alert for EpiPens and other epinephrine auto-injectors May 9, after patients and pharmacists in 45 states reported it was difficult to find the lifesaving allergic reaction treatment.  By Alia Paavola - 5/9/18